Balance Sheet Components - Accrued and Other Current Liabilities (Details) - USD ($) $ in Thousands |
Sep. 30, 2023 |
Dec. 31, 2022 |
|---|---|---|
| Balance Sheet Components | ||
| Accrued commercial and research and development manufacturing | $ 17,057 | $ 21,774 |
| Accrued co-development costs payable to Junshi Biosciences | 1,293 | 8,356 |
| Accrued royalties | 30,557 | 5,015 |
| Accrued other | 9,698 | 10,634 |
| Lease liabilities, current | 4,469 | 4,318 |
| Contingent consideration, current | 4,040 | |
| Total Accrued and other current liabilities | $ 67,114 | $ 50,097 |
| X | ||||||||||
- Definition Represent to pertaining accrued co-development costs payable to Junshi Biosciences No definition available.
|
| X | ||||||||||
- Definition Accrued commercial and research and development manufacturing liabilities current. No definition available.
|
| X | ||||||||||
- Definition Represents lease liabilities for both operating and financing leases. No definition available.
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|